Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders

Bahaa Abu-Raya; Shabir A. Madhi; Saad B. Omer; Gayatri Amirthalingam; Michelle L. Giles; Katie L. Flanagan; Petra Zimmermann; Miguel O’Ryan; Marco A. Safadi; Vassiliki Papaevangelou; Kirsten Maertens; Nasamon Wanlapakorn; Vicens Diaz-Brito; Eline Tommelein; Susanna Esposito

doi:10.3389/fimmu.2021.808064

Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders

Bahaa Abu-Raya, Shabir A. Madhi, Saad B. Omer, Gayatri Amirthalingam, Michelle L. Giles, Katie L. Flanagan, Petra Zimmermann, Miguel O’Ryan, Marco A. Safadi, Vassiliki Papaevangelou, Kirsten Maertens, Nasamon Wanlapakorn, Vicens Diaz-Brito, Eline Tommelein, Susanna Esposito

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

Original language	English (US)
Article number	808064
Journal	Frontiers in immunology
Volume	12
DOIs	https://doi.org/10.3389/fimmu.2021.808064
State	Published - Dec 23 2021
Externally published	Yes

Keywords

COVID-19
SARS-CoV-2
maternal immunization
maternal vaccination program
pregnant women

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.3389/fimmu.2021.808064

Fingerprint

Dive into the research topics of 'Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders'. Together they form a unique fingerprint.

Cite this

Abu-Raya, B., Madhi, S. A., Omer, S. B., Amirthalingam, G., Giles, M. L., Flanagan, K. L., Zimmermann, P., O’Ryan, M., Safadi, M. A., Papaevangelou, V., Maertens, K., Wanlapakorn, N., Diaz-Brito, V., Tommelein, E., & Esposito, S. (2021). Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders. Frontiers in immunology, 12, Article 808064. https://doi.org/10.3389/fimmu.2021.808064

Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders. / Abu-Raya, Bahaa; Madhi, Shabir A.; Omer, Saad B. et al.
In: Frontiers in immunology, Vol. 12, 808064, 23.12.2021.

Research output: Contribution to journal › Review article › peer-review

Abu-Raya, B, Madhi, SA, Omer, SB, Amirthalingam, G, Giles, ML, Flanagan, KL, Zimmermann, P, O’Ryan, M, Safadi, MA, Papaevangelou, V, Maertens, K, Wanlapakorn, N, Diaz-Brito, V, Tommelein, E & Esposito, S 2021, 'Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders', Frontiers in immunology, vol. 12, 808064. https://doi.org/10.3389/fimmu.2021.808064

Abu-Raya B, Madhi SA, Omer SB, Amirthalingam G, Giles ML, Flanagan KL et al. Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders. Frontiers in immunology. 2021 Dec 23;12:808064. doi: 10.3389/fimmu.2021.808064

@article{afad16af29c846b19986bd5e80039eb4,

title = "Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders",

abstract = "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.",

keywords = "COVID-19, SARS-CoV-2, maternal immunization, maternal vaccination program, pregnant women",

author = "Bahaa Abu-Raya and Madhi, {Shabir A.} and Omer, {Saad B.} and Gayatri Amirthalingam and Giles, {Michelle L.} and Flanagan, {Katie L.} and Petra Zimmermann and Miguel O{\textquoteright}Ryan and Safadi, {Marco A.} and Vassiliki Papaevangelou and Kirsten Maertens and Nasamon Wanlapakorn and Vicens Diaz-Brito and Eline Tommelein and Susanna Esposito",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 Abu-Raya, Madhi, Omer, Amirthalingam, Giles, Flanagan, Zimmermann, O{\textquoteright}Ryan, Safadi, Papaevangelou, Maertens, Wanlapakorn, Diaz-Brito, Tommelein and Esposito.",

year = "2021",

month = dec,

day = "23",

doi = "10.3389/fimmu.2021.808064",

language = "English (US)",

volume = "12",

journal = "Frontiers in immunology",

issn = "1664-3224",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research

T2 - An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders

AU - Abu-Raya, Bahaa

AU - Madhi, Shabir A.

AU - Omer, Saad B.

AU - Amirthalingam, Gayatri

AU - Giles, Michelle L.

AU - Flanagan, Katie L.

AU - Zimmermann, Petra

AU - O’Ryan, Miguel

AU - Safadi, Marco A.

AU - Papaevangelou, Vassiliki

AU - Maertens, Kirsten

AU - Wanlapakorn, Nasamon

AU - Diaz-Brito, Vicens

AU - Tommelein, Eline

AU - Esposito, Susanna

PY - 2021/12/23

Y1 - 2021/12/23

N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

KW - COVID-19

KW - SARS-CoV-2

KW - maternal immunization

KW - maternal vaccination program

KW - pregnant women

UR - http://www.scopus.com/inward/record.url?scp=85122478108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122478108&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2021.808064

DO - 10.3389/fimmu.2021.808064

M3 - Review article

C2 - 35003137

AN - SCOPUS:85122478108

SN - 1664-3224

VL - 12

JO - Frontiers in immunology

JF - Frontiers in immunology

M1 - 808064

ER -

Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this